Core Viewpoint - Westlake Corporation has received various analyst ratings, with a mix of buy, hold, and outperform recommendations, indicating a generally positive outlook despite recent stock performance fluctuations [1][7]. Financial Performance - Westlake reported a quarterly earnings loss of $0.25 per share, surpassing analysts' expectations of a loss of $1.47 by $1.22. The company's revenue for the quarter was $2.53 billion, slightly below the consensus estimate of $2.61 billion, marking a year-over-year revenue decline of 10.9% [3]. - The company has a market capitalization of $14.48 billion, a PE ratio of -9.67, and a beta of 0.83. Its 50-day and 200-day simple moving averages are $99.39 and $83.07, respectively. The stock has a 52-week low of $56.33 and a high of $116.46 [2]. Dividend Information - Westlake declared a quarterly dividend of $0.53 per share, with an annualized dividend of $2.12, resulting in a dividend yield of 1.9%. The payout ratio stands at -18.12% [4]. Insider Activity - CFO Mark Steven Bender sold 17,409 shares at an average price of $100.92, totaling approximately $1.76 million. This sale reduced his holdings by 28.15% [5]. Institutional Investment - Institutional investors have shown varied interest in Westlake, with notable transactions including Norges Bank acquiring a stake valued at approximately $104.31 million and Citigroup increasing its stake by 61.3% [6][8]. Currently, institutional investors hold 28.40% of the company's stock [8]. Company Profile - Westlake Corporation is a global manufacturer specializing in petrochemicals, polymers, and building products, primarily producing vinyls and chlor-alkali products. The company operates a network of vertically integrated plants and distribution centers across North America, Europe, and Asia [9][10].

Summary of Wanhua Chemical - A Conference Call Company Overview - **Company**: Wanhua Chemical - **Ticker**: 600309.SS, 600309 CH - **Market Cap**: $31.46 billion - **Price Target**: Rmb70.00 (as of Dec 2026) [2][3][12] Key Financial Highlights - **4Q25 Net Profit (NP)**: Rmb3.37 billion, representing an increase of 11% quarter-over-quarter (q/q) and 74% year-over-year (y/y) [2][9] - **FY25 NP**: Rmb12.5 billion, in line with consensus estimates [2][9] - **Revenue Growth**: Expected to grow from Rmb203.24 billion in FY25 to Rmb267.50 billion in FY28, with a y/y growth rate of 11.6% in FY25 [11][29] - **Adjusted EPS**: Increased from Rmb4.20 in FY26E to Rmb4.81, a 14.4% increase; FY27E adjusted EPS increased from Rmb4.90 to Rmb5.20, a 6% increase [5][11] Industry Context - **Logistical Disruption**: Wanhua declared force majeure for all product shipments to the Middle East on March 7, 2026, due to severe disruptions in the Strait of Hormuz, impacting delivery capabilities [2][9] - **MDI Price Surge**: MDI prices increased by $100/ton in February 2026, with major producers like Dow announcing price hikes of $200-$300/ton [9] - **China's MDI Exports**: The Middle East accounted for 17% of China's MDI exports, totaling 9.3 million tons per annum (Mtpa) in 2025 [9] Operational Insights - **Earnings Contribution**: The earnings contribution from the Yantai ethylene cracker conversion is expected to be negligible in 4Q25, with investor focus on the operational status of PDH facilities [2][9] - **Upcoming Announcements**: Full FY25 results will be announced on April 21, 2026, with key focus areas including the volume impact from the Middle East conflict and the ramp-up status of new capacities [9] Valuation and Investment Thesis - **Valuation Methodology**: Price target of Rmb70 is based on a 15x one-year forward P/E, consistent with the historical five-year average [12][26] - **Long-term Outlook**: Wanhua is viewed positively for its global cost leadership in MDI and growth potential in fine chemicals, despite risks from the US-China trade war and tariff hikes [12][25] Risks and Considerations - **Upside Risks**: Potential de-escalation in US-China trade conflicts and competitor force majeure due to extreme weather or logistics issues [27] - **Downside Risks**: Further escalation of trade tariffs, global recession risks affecting chemical demand, and potential tariff hikes on China MDI by European/US allies [27] Additional Metrics - **Dividend Yield**: Expected to increase from 1.5% in FY25 to 2.0% in FY28 [11][29] - **Net Debt/Equity Ratio**: Expected to decrease from 0.7 in FY25 to 0.5 in FY28, indicating improved financial leverage [11][29] This summary encapsulates the key points from the conference call regarding Wanhua Chemical, highlighting financial performance, industry context, operational insights, valuation, and associated risks.

Core Insights - The success of Berkshire Hathaway (BRK.B) is attributed to its disciplined capital allocation strategy, which focuses on investing only when risk-adjusted returns are favorable, thereby compounding shareholder wealth while minimizing the risk of permanent capital loss [1][4] Group 1: Capital Allocation Strategy - Berkshire Hathaway's disciplined approach is evident in its acquisition of OxyChem and Bell Laboratories in 2025, which enhances its operational portfolio by generating stable cash flow and offering long-term growth potential [2][8] - The company maintains significant cash and U.S. Treasury holdings exceeding $370 billion and a float of $176 billion, which supports its prudent capital allocation strategy [3][8] - Berkshire repurchases shares only when they are undervalued, which increases shareholder value by enhancing ownership stakes in its high-quality business portfolio [3] Group 2: Performance and Valuation - Year-to-date, BRK.B shares have decreased by 1.7%, although this performance is better than the industry average [7] - The price-to-book value ratio for BRK.B is 1.47, which is above the industry average of 1.38, indicating a relatively expensive valuation [10] - The Zacks Consensus Estimate for BRK.B's first-quarter 2026 EPS has increased by 0.8% over the last 30 days, while estimates for 2026 and 2027 EPS have decreased by 0.8% each [11][12]

Core Insights - Chemtrade Logistics Income Fund is facing margin pressure in its Sulphur and Water Chemicals (SWC) segment due to sharp raw material inflation, particularly in sulphur, and fixed annual pricing in municipal contracts [5][8] - The company plans to report its water chemicals business as a separate segment starting Q1 2026, although detailed financial metrics for this segment are not yet available [7][9] - Management anticipates a turnaround in North Vancouver in Q2 2026, which may negatively impact near-term results due to maintenance activities [6][10] Segment Performance - The Merchant Acid business is more responsive to sulphur-driven cost changes and can implement price increases more quickly compared to the water chemicals segment [1] - In the water chemicals business, Chemtrade may initially absorb rising raw material costs, but this can compress margin percentages even if EBITDA remains protected [2][3][8] - The company expects caustic soda pricing to recover in the second half of 2026 after a weak start to the year, driven by underlying demand factors [14] Operational Updates - Management indicated that 2026 will see heavier maintenance in the SWC segment, which is tied to customer turnaround schedules, and this is expected to be more significant than in the past two years [15] - The company is also upgrading its Tulsa facility in connection with its Cairo facility, which is expected to enhance product quality and meet customer demands [16] - The approval process for Cairo's output is progressing positively, with expectations for sales volume to ramp up in the second half of the year [16] Financial Outlook - Management expects corporate program costs in 2026 to be similar to those in 2025 after normalizing for incentive-related fluctuations [12] - The company has provided outage assumptions for modeling purposes, estimating costs in the range of CAD 22 million to CAD 28 million [13] - 2025 was noted as a record year for Chemtrade, reflecting strong operational performance [18]

Core Insights - Westlake Corporation (WLK) reported a significant net loss of $544 million or $4.22 per share for Q4 2025, contrasting with a profit of $7 million or 6 cents per share in the same quarter of the previous year. The adjusted loss per share was 25 cents, which was better than the Zacks Consensus Estimate of a loss of $1.44 [1][9]. Financial Performance - Sales decreased by approximately 10.9% year over year to $2,533 million in Q4 2025, falling short of the Zacks Consensus Estimate of $2,567.4 million. This decline was attributed to lower average sales prices and reduced sales volume [2]. - The fourth quarter results were adversely affected by increased feedstock and energy costs, as well as the shutdown of three chlorovinyl production facilities and one styrene facility in North America, leading to noncash accelerated depreciation and asset write-off charges [3]. Segment Performance - The Performance and Essential Materials (PEM) segment experienced a sales decline of around 12.4% year over year to $1,632 million, missing the estimate of $1,652 million. The segment reported a loss from operations of $717 million, a significant increase from a loss of $41 million in Q4 2024, primarily due to lower selling prices and reduced sales volume of key products [4]. - The Housing and Infrastructure Products (HIP) segment generated sales of $901 million, down about 8.1% from the previous year, also missing the estimate of $1,008 million. The income from operations in this segment fell to $66 million, down $129 million from Q4 2024, driven by lower sales volume and margins [5]. Financial Position - Operating activities generated $225 million in net cash during Q4 2025, while capital expenditures were $241 million, resulting in a free cash outflow of $16 million. As of December 31, 2025, the company had approximately $2.7 billion in cash and cash equivalents, with long-term debt amounting to $5.1 billion [6]. Future Outlook - Westlake anticipates an improvement in profitability for 2026, despite ongoing challenges from weak global industrial and manufacturing activity. The company is implementing cost-cutting measures and aims to enhance PEM profitability to achieve a targeted $600 million in EBITDA improvement. Additionally, the HIP segment is expected to benefit from the acquisition of ACI in January 2026 [7].

4Q25 & FY25 Earnings Call J a n u a r y 3 0 , 2 0 2 6 Forward-looking Statements 1 Value-first commercial approach continues to preserve ECU values 2 Announced Braskem long-term agreement, upgrading our export EDC values 3 Successful Epoxy volume growth amid European capacity closures 4 Winchester reduced commercial production accelerating destocking 5 Generated $321M of operating cash flow, keeping net debt flat year-over-year Chlor Alkali Products & Vinyls Segment Performance This presentation includes fo ...

Core Insights - Olin Corporation reported a net loss of $85.7 million for Q4 2025, a significant decline from a net income of $10.7 million in Q4 2024, reflecting ongoing market challenges and operational disruptions [1][2] - The company's adjusted EBITDA for Q4 2025 was $67.7 million, down from $193.4 million in Q4 2024, indicating a substantial decrease in operational profitability [1][27] - Total sales for Q4 2025 were $1,665.1 million, slightly lower than $1,671.3 million in Q4 2024, showing a stable revenue stream despite adverse conditions [1][21] Financial Performance - The full year 2025 reported a net loss of $42.8 million, compared to a net income of $108.6 million in 2024, highlighting a year-over-year decline in profitability [1][21] - Operating cash flow for Q4 2025 was $321.2 million, demonstrating effective cash generation despite the net loss [2] - The company ended 2025 with net debt of approximately $2.7 billion, maintaining a net debt to adjusted EBITDA ratio of 4.1 times, indicating a stable leverage position [12][32] Segment Performance - Chlor Alkali Products and Vinyls segment reported sales of $856.4 million in Q4 2025, down from $953.7 million in Q4 2024, primarily due to lower pricing [6][7] - The Epoxy segment saw sales increase to $359.3 million in Q4 2025 from $282.2 million in Q4 2024, driven by higher volumes, although it still reported a segment loss of $19.2 million [8] - Winchester segment sales were $449.4 million in Q4 2025, up from $435.4 million in Q4 2024, with military sales offsetting declines in commercial ammunition [9] Strategic Initiatives - The company is focused on its "Optimize the Core" strategic priorities, which include enhancing operational reliability and achieving structural cost reductions through the Beyond250 initiative, which has already realized $44 million in cost savings in 2025 [2][3] - Olin plans to close its epoxy resin manufacturing facility in Guarujá, Brazil, in Q1 2026, expecting to achieve annual structural cost savings of approximately $10 million [11] - The company anticipates that its Epoxy business will return to profitability in 2026, supported by new supply agreements and ongoing cost reduction efforts [3]

Core Insights - Warren Buffett will retire at age 95 after over 60 years of running Berkshire Hathaway, making a significant investment in OxyChem for $9.7 billion just before his departure [1][2] Group 1: Acquisition Details - Berkshire Hathaway is acquiring OxyChem, a petrochemicals business from Occidental Petroleum, marking its most significant acquisition since 2022 [2] - The acquisition price of $9.7 billion is considered a bargain, with OxyChem being valued at about eight times its projected 2025 EBITDA, especially in a weak chemical industry [3] - OxyChem is a stable cash generator producing essential products like chlorine, caustic soda, and PVC, which are crucial for various industries [4] Group 2: Financial Implications - The structure of the deal benefits both companies, with Occidental Petroleum receiving $9.7 billion in cash, planning to use $6.5 billion to reduce its debt below $15 billion, thus improving its balance sheet [5] - This debt reduction is expected to save Occidental $350 million to $400 million annually in interest payments, enhancing Berkshire's existing 28.2% ownership and providing additional protection against energy price volatility [5]

Core Viewpoint - Olin Corporation has revised its fourth quarter 2025 adjusted EBITDA outlook to approximately $67 million, significantly lower than the previous estimate of $110 to $130 million, primarily due to issues in the Chlor Alkali Products and Vinyls business [1][2]. Company Overview - Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products, including chlorine, caustic soda, vinyls, and various other chemicals, as well as a major U.S. manufacturer of ammunition [3]. Financial Performance - The adjusted EBITDA for the fourth quarter 2025 is now expected to be around $67 million, a decrease from the earlier forecast of $110 to $130 million [1]. - The earnings shortfall is attributed to an extended planned maintenance turnaround and unplanned downtime at the Freeport, Texas operations, along with lower-than-expected pipeline chlorine demand [1][2]. Operational Challenges - The Chlor Alkali Products and Vinyls segment faced a significant decline in chlorine demand and operational issues at the Freeport site, which included a planned turnaround and interruptions in raw material supply from a third party [2]. - The Freeport site has since returned to normal operations, but the impact of these challenges has affected the overall financial outlook [2].

RESPONSIBLE CARE® OUR COMMITMENT TO SUSTAINABILITY Refer to the Appendix for additional notices of caution regarding forward looking information. 2 TSX: CHE.UN 2026 Guidance 2026 Guidance: 2026 GUIDANCE Chemtrade Logistics Income Fund (TSX: CHE.UN) January 8, 2026 CAUTION REGARDING FORWARD- LOOKING STATEMENTS Certain statements contained in this presentation constitute forward-looking statements within the meaning of certain securities laws, including the Securities Act (Ontario). Forward-looking statements ...